Arrive AI's Mark Hamm to Resign as COO and Director, Effective Oct 2, 2026

Arrive AI (ARAI) shares rose over 20% premarket after announcing a premium-priced direct investment from a U.S. private investment firm at $0.65 per unit.

Arrive AI (ARAI) held its Q2 2026 earnings call. Management reported revenue of $14.7 million, a net loss of $14.1 million, and non-GAAP net loss of $4.3 million. Cash and liquid investments were $5.1 million at June 30, with about $1.1 million monthly burn. The company outlined AP3 Plus shipments, a 2027 ramp, and financing capacity via an S-3 and $15 million ATM.

Arrive AI (NASDAQ:ARAI) said it has released Arrive OS, the software platform that powers its Arrive Points and connects them via the Arrive Point Network. The company says Arrive Points can gain new capabilities through over-the-air updates, avoiding hardware replacement. Arrive OS is designed to support scalable, interconnected autonomous logistics deployments across enterprise sectors.

Integra LifeSciences (IART) raised $2.1B on Oct 19, 2026, via new credit facilities and a notes offering. The company secured $1.65B in senior secured credit facilities and $450M in 9.500% senior secured notes due 2033. Proceeds were used to repay and terminate the 2023 credit agreement, enhancing liquidity and extending debt maturities.

Disc Medicine (IRON) announced a $350M public offering of common stock and pre-funded warrants, with a 30-day option for underwriters to buy additional shares. The biopharmaceutical company aims to raise capital through this offering.

Enerpac Tool Group refinanced its debt with a $550M revolving credit line and a $300M term loan, both maturing in 2031. The deal includes pricing tied to SOFR and an accordion option for up to $425M more. PNC Bank acted as the administrative agent.